Differential Effect of Eculizumab and Efgartigimod on Subscores of the MG-ADL and QMG in Generalized Myasthenia Gravis Patients

Self-administration of Rozanolixizumab in Patients with Generalized Myasthenia Gravis: The MG0020 Study